Work

Abstract 854: Patient stratification strategies for NVP-BGJ398, a selective pan-FGFR inhibitor in phase I clinical trials

Year: 2012

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2012-854

Authors: Diana Graus Porta, Vito Guagnano, Christelle Stamm, Simon Woehrle, Audrey Kauffmann, Yao Yao, Thomas Brümmendorf, Vincent Bordas, Mickaël Le Douget, Yun Zhang, Zhi Chen, Moriko Ito, Fang Li, John Monahan, Alex Gaither, Jason Borawski, Christopher J. Wilson, Kavitha Venkatesan, Francesco Hofmann, William Sellers

Institution: Novartis (Switzerland)

Language: English

Topic: Fibroblast Growth Factor Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2062950819

Cites:

Cited by: 1

Related to: 10